New hope for Tough-to-Treat colon cancer: Two-Drug combo goes Head-to-Head with standard care
NCT ID NCT04776148
Summary
This study tested whether a combination of two drugs, lenvatinib and pembrolizumab, could help people live longer than the standard treatments for metastatic colorectal cancer that has stopped responding to prior therapies. It involved 563 participants whose cancer had spread and worsened after they had tried all other approved treatment options. The main goal was to see if this new combination improved overall survival compared to the usual care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL NEOPLASMS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Acıbadem Maslak Hastanesi ( Site 1307)
Istanbul, 34457, Turkey (Türkiye)
-
Addenbrooke's Hospital ( Site 1407)
Cambridge, Cambridgeshire, CB2 0QQ, United Kingdom
-
Aichi Cancer Center Hospital ( Site 1701)
Nagoya, Aichi-ken, 4648681, Japan
-
Asan Medical Center ( Site 1803)
Seoul, 05505, South Korea
-
Asklepios Altona-Oncology ( Site 0903)
Hamburg, 22763, Germany
-
Blue Ridge Cancer Care ( Site 0036)
Roanoke, Virginia, 24014, United States
-
CHU de Quebec - Université Laval - Hotel Dieu de Quebec-Hemato-Dermato-Gyneco-Oncology ( Site 0203)
Québec, Quebec, G1R 3S1, Canada
-
CIUSSS de l'Est-de-l'Île-de-Montréal ( Site 0211)
Montreal, Quebec, H1T 2M4, Canada
-
Centro de Educación Médica e Investigaciones Clínicas (CEMIC)-Medical Oncology ( Site 0303)
Buenos Aires, 1431, Argentina
-
Chang Gung Medical Foundation.Linkou Branch ( Site 1902)
Taoyuan District, 333, Taiwan
-
Charité Universitaetsmedizin Berlin - Campus Mitte ( Site 0901)
Berlin, 10117, Germany
-
China Medical University Hospital-Surgical Department ( Site 1903)
Taichung, 40447, Taiwan
-
Cross Cancer Institute-Department of Medical Oncology ( Site 0207)
Edmonton, Alberta, T6G 1Z2, Canada
-
Ege University Medicine of Faculty-Medical Oncology ( Site 1305)
Izmir, 35100, Turkey (Türkiye)
-
Epworth Freemasons ( Site 1506)
Melbourne, Victoria, 3002, Australia
-
Fed State Budgetary Inst N.N. Blokhin Med Center of Oncology MHRF ( Site 1107)
Moscow, Moscow, 115478, Russia
-
First Moscow State Medical University I.M. Sechenov-Interhospital Institution ""Health Management (
Moscow, Moscow, 119991, Russia
-
Fundación favaloro para la Docencia e Investigación Médica-Oncología ( Site 0301)
Buenos Aires, Buenos Aires F.D., C1096AAS, Argentina
-
GBUZ Republican Clinical Oncological Dispensary-Antitumor drug therapy department ( Site 1109)
Ufa, Baskortostan, Respublika, 450054, Russia
-
Gallipoli Medical Research Foundation-GMRF CTU ( Site 1500)
Greenslopes, Queensland, 4120, Australia
-
Guy's & St Thomas' NHS Foundation Trust ( Site 1404)
London, London, City of, SE1 9RT, United Kingdom
-
HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑON ( Site 1205)
Madrid, 28007, Spain
-
Hacettepe Universitesi-oncology hospital ( Site 1302)
Ankara, 06230, Turkey (Türkiye)
-
Hadassah Medical Center-Oncology ( Site 0802)
Jerusalem, 9112001, Israel
-
Hamilton Health Sciences-Juravinski Cancer Centre ( Site 0205)
Hamilton, Ontario, L8V 4X2, Canada
-
Henry Ford Hospital ( Site 0024)
Detroit, Michigan, 48202, United States
-
Herlev and Gentofte Hospital-Department of Oncology ( Site 0704)
Copenhagen, Capital Region, 2730, Denmark
-
Hollywood Private Hospital-Medical Oncology ( Site 1507)
Perth, Western Australia, 6009, Australia
-
Hospital Británico de Buenos Aires-Oncology ( Site 0308)
Ciudad Autónoma de Buenos Aires, Buenos Aires, C1280AEB, Argentina
-
Hospital Universitari Vall d'Hebron-Oncology ( Site 1204)
Barcelona, 08035, Spain
-
Hospital Universitario Central de Asturias-Digestive ( Site 1200)
Oviedo, Principality of Asturias, 33011, Spain
-
Hospital Universitario Marqués de Valdecilla ( Site 1201)
Santander, Cantabria, 39008, Spain
-
Hospital Universitario Virgen de Valme-Departamento de Oncologia ( Site 1207)
Seville, 41014, Spain
-
IDIM - Instituto de Diagnóstico e Investigaciones Metabólicas ( Site 0300)
Buenos Aires, C1012AAR, Argentina
-
Inova Schar Cancer Institute ( Site 0022)
Fairfax, Virginia, 22031, United States
-
Instituto de Oncología de Rosario ( Site 0305)
Rosario, Santa Fe Province, S2000KZE, Argentina
-
Istanbul Universitesi Cerrahpasa-Medical Oncology ( Site 1300)
Istanbul, 34668, Turkey (Türkiye)
-
Japanese Foundation for Cancer Research-GI Oncology ( Site 1710)
Tokyo, 135-8550, Japan
-
Kagawa University Hospital ( Site 1708)
Kita, Kagawa-ken, 761-0701, Japan
-
Kanagawa cancer center ( Site 1705)
Yokohama, Kanagawa, 2418515, Japan
-
Kindai University Hospital- Osakasayama Campus-Medical Oncology ( Site 1704)
Sayama, Osaka, 589-8511, Japan
-
Klinikum am Steinenberg-Kreiskliniken Reutlingen GmbH ( Site 0908)
Reutlingen, Baden-Wurttemberg, 72764, Germany
-
Kobe City Medical Center General Hospital ( Site 1707)
Kobe, Hyōgo, 650-0047, Japan
-
Korea University Anam Hospital ( Site 1806)
Seoul, 02841, South Korea
-
MFSMC-HJWCI-Oncology Research ( Site 0012)
Baltimore, Maryland, 21237, United States
-
MedStar Good Samaritan Hospital-Oncology Research ( Site 0038)
Baltimore, Maryland, 21239, United States
-
Memorial Ankara Hastanesi-Medical Oncology ( Site 1304)
Ankara, 06520, Turkey (Türkiye)
-
NATIONAL CHENG-KUNG UNI. HOSP. ( Site 1904)
Tainan, 704, Taiwan
-
NSHA-QEII Health Sciences Centre-Dickson Bldg-Dept. of Medical Oncology ( Site 0200)
Halifax, Nova Scotia, B3H 2Y9, Canada
-
National Cancer Center Hospital ( Site 1702)
Tokyo, 104-0045, Japan
-
National Cancer Center Hospital East ( Site 1700)
Kashiwa, Chiba, 277-8577, Japan
-
National Hospital Organization Kyushu Cancer Center ( Site 1709)
Fukuoka, 811-1395, Japan
-
National Taiwan University Hospital ( Site 1900)
Taipei, 10002, Taiwan
-
North York General Hospital ( Site 0206)
Toronto, Ontario, M2K1E1, Canada
-
Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital ( Site 0021)
Marietta, Georgia, 30060, United States
-
Northwest Medical Specialties, PLLC ( Site 0033)
Tacoma, Washington, 98405, United States
-
Odense Universitetshospital ( Site 0700)
Odense, Region Syddanmark, 5000, Denmark
-
Onkodok GmbH ( Site 0907)
Gütersloh, North Rhine-Westphalia, 33332, Germany
-
Pacific Cancer Care ( Site 0031)
Monterey, California, 93940, United States
-
Providence Portland Medical Center ( Site 0019)
Portland, Oregon, 97213, United States
-
ROYAL MARSDEN HOSPITAL (CHELSEA) ( Site 1403)
London, London, City of, SW3 6JJ, United Kingdom
-
Rambam Health Care Campus-Oncology ( Site 0800)
Haifa, 3109601, Israel
-
Rigshospitalet ( Site 0702)
Copenhagen, Capital Region, 2100, Denmark
-
Royal Brisbane and Women's Hospital-Medical Oncology Clinical Trials Unit, Cancer Care Services ( Si
Brisbane, Queensland, 4029, Australia
-
Royal Marsden Hospital (Sutton) ( Site 1409)
London, Surrey, SM3 5PT, United Kingdom
-
SHBI Leningrad Regional Clinical Oncology Dispensary-Clinical Trials Department ( Site 1111)
Saint Petersburg, 188663, Russia
-
SUN YAT-SEN UNIVERSITY CANCER CENTRE ( Site 1600)
Guangzhou, Guangdong, 510060, China
-
SVERDLOVSK REGIONAL ONCOLOGY DISPENSARY ( Site 1108)
Yekaterinburg, Sverdlovsk Oblast, 620905, Russia
-
Saint-Petersburg City Clinical Oncology Dispensary-Department of chemotherapy ( Site 1100)
Saint Petersburg, Leningradskaya Oblast', 198255, Russia
-
Saitama Prefectural Cancer Center ( Site 1703)
Ina-machi, Saitama, 362-0806, Japan
-
Samsung Medical Center-Division of Hematology/Oncology ( Site 1804)
Seoul, 06351, South Korea
-
Seoul National University Hospital-Internal Medicine ( Site 1800)
Seoul, 03080, South Korea
-
Severance Hospital, Yonsei University Health System-Medical oncology ( Site 1801)
Seoul, 03722, South Korea
-
Shaare Zedek Medical Center-Oncology ( Site 0804)
Jerusalem, 9013102, Israel
-
Sheba Medical Center ( Site 0803)
Ramat Gan, 5262100, Israel
-
Shizuoka Cancer Center ( Site 1706)
Nakatogari, Shizuoka, 411-8777, Japan
-
Sir Run Run Shaw Hospital-Medical Oncology ( Site 1606)
Hangzhou, Zhejiang, 310016, China
-
Sourasky Medical Center-Oncology ( Site 0801)
Tel Aviv, 6423906, Israel
-
St. Vincent Frontier Cancer Center ( Site 0005)
Billings, Montana, 59102, United States
-
TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi-oncology ( Site 1301)
Istanbul, 34722, Turkey (Türkiye)
-
Taipei Veterans General Hospital-Oncology ( Site 1901)
Taipei, 11217, Taiwan
-
The Catholic Univ. of Korea Seoul St. Mary's Hospital ( Site 1802)
Seoul, 06591, South Korea
-
The Christie-Medical Oncology ( Site 1411)
Manchester, M20 4BX, United Kingdom
-
The First People's Hospital of Foshan-Gastrointestinal oncology ( Site 1604)
Foshan, Guangdong, 528041, China
-
The National Medico-Surgical Center N.I. Pirogov ( Site 1102)
Moscow, Moscow, 105203, Russia
-
The Queen Elizabeth Hospital-Cancer Clinical Trials ( Site 1503)
Woodville, South Australia, 5011, Australia
-
Thomas Jefferson University - Clinical Trials Office ( Site 0027)
Philadelphia, Pennsylvania, 19107, United States
-
Trakya University-Oncology ( Site 1303)
Edirne, 22030, Turkey (Türkiye)
-
UCLH-Cancer Clinical Trials Unit ( Site 1400)
London, Essex, NW1 2PG, United Kingdom
-
University of Chicago Medical Center-Medicine - Section of Hematology/Oncology - Gastrointestinal P
Chicago, Illinois, 60637, United States
-
Vejle Sygehus-Department of Oncology ( Site 0701)
Vejle, Region Syddanmark, DK-7100, Denmark
-
Western General Hospital ( Site 1401)
Edinburgh, Midlothian, EH4 2XU, United Kingdom
-
Western Health-Sunshine & Footscray Hospitals ( Site 1501)
St Albans, Victoria, 3021, Australia
-
klinikum rechts der isar der technischen universität münchen-Klinik und Poliklinik für Innere Mediz
Munich, Bavaria, 81675, Germany
-
İnönü Üniversitesi Turgut Özal Tıp Merkezi ( Site 1306)
Malatya, 44280, Turkey (Türkiye)
Conditions
Explore the condition pages connected to this study.